RESMED INC — Director's Dealing 2010

Dec 30, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-12-28

Reporting Person: FARRELL PETER C (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-12-28	ResMed Common Stock	G	138962	—	Disposed	533230	Direct
2010-12-29	ResMed Common Stock	S	61038	$35.04	Disposed	0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	200000	Indirect
ResMed Common Stock	200000	Indirect

Footnotes

F1: Trade executed pursuant to 10b5-1 trading plan.

F2: Transaction represents a distribution from the Peter C. Farrell December 2009 Annuity Trust (the "Trust") of 138,962 shares to the Peter C. Farrell Family Trust (of which Dr. Farrell is the Trustee). Per the terms of the trust, 90% of the original value was transferred to Dr. Farrell at the end of the first year.

F3: Transaction represents the sale of the remaining shares in the Trust for cash, which was retained by the Trust.

F4: The price reported is the weighted average price. The shares were acquired in multiple transactions at prices ranging from $34.95 to $35.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.